
|Articles|October 3, 2007
Pediatric Lamisil granules get FDA nod
Lamisil oral granules are approved by the FDA for tinea capitis
Advertisement
Terbinafine (Lamisil, Novartis) oral granules have been approved for the treatment of tinea capitis in children aged four years and older. Novartis developed the new formulation in response to a written request from the FDA for the product. The granules can be sprinkled on food and are approved to be administered once daily for six weeks.
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Orforglipron Maintains Weight Loss After Discontinuation of Injectable GLP-1
2
Q&A: Reproductive Health Training Equips Pharmacists to Close Care Gaps
3
Rethinking Acute Pain Management in the Age of Prescription Topicals
4
FDA Approves Tradipitant for Prevention of Vomiting From Motion Sickness
5














































































































